Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bf7439808d578ab8c3698f7560fe4ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dd98ad4ee076841fec541542f952f58 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55583 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-523 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-012 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-012 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-002 |
filingDate |
2014-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9869d1e9c00e026177c5727d105d1101 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5804d9b5d467e1e7248feb4036f5e74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff6e961f15ecb6748392bd009f1cd92b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adcd69a10404353555ca3a08ba15d66c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cca19e933eec4c8c5cbdf029d05a81aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_187291ad7557e8b67fd24cfb8af2189d |
publicationDate |
2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2014216246-B2 |
titleOfInvention |
Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection |
abstract |
Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine vectors include a polynucleotide encoding a Rhomboid polypeptide and optionally include an immune-stimulatory polypeptide suitably expressed on the surface of the vaccine vector. |
priorityDate |
2013-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |